T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Expedia Group
EXPE
$39.4B
| $21M | ﹤0.01% |
191,816
-4,076,559
| -96% | -$400M |
|
927
Globe Life
GL
$14B
| $20.9M | ﹤0.01% |
190,951
+59,476
| +45% | +$6.39M |
|
|
AMED
928
DELISTED
Amedisys
AMED
| $20.9M | ﹤0.01% |
228,181
-21,982
| -9% | -$1.8M |
|
929
J.M. Smucker
SJM
$12.9B
| $20.9M | ﹤0.01% |
141,209
+1,237
| +0.9% | +$189K |
|
930
Snap-on
SNA
$20.9B
| $20.6M | ﹤0.01% |
71,592
-268
| -0.4% | -$69.4K |
|
931
Cincinnati Financial
CINF
$26.5B
| $20.6M | ﹤0.01% |
211,782
+979
| +0.5% | +$101K |
|
932
Bentley Systems
BSY
$11B
| $20.5M | ﹤0.01% |
378,013
+5,748
| +2% | +$268K |
|
933
Rapid7
RPD
$929M
| $20.3M | ﹤0.01% |
448,340
+235
| +0.1% | +$10.9K |
|
934
Moog Inc Class A
MOG.A
$13.5B
| $20.2M | ﹤0.01% |
186,079
-46,348
| -20% | -$4.6M |
|
935
Jacobs Solutions
J
$16.8B
| $20.1M | ﹤0.01% |
204,549
| – | – |
|
|
NVEE
936
DELISTED
NV5 Global
NVEE
| $20M | ﹤0.01% |
722,784
-3,780
| -0.5% | -$92.7K |
|
937
Synchrony
SYF
$26.1B
| $19.9M | ﹤0.01% |
586,275
-9,925
| -2% | -$303K |
|
938
Lumentum
LITE
$78B
| $19.9M | ﹤0.01% |
350,092
-134,306
| -28% | -$6.71M |
|
939
Akamai
AKAM
$18B
| $19.8M | ﹤0.01% |
219,865
-2,195
| -1% | -$188K |
|
940
Revvity
RVTY
$13.1B
| $19.7M | ﹤0.01% |
165,645
-12,636
| -7% | -$1.55M |
|
941
Vir Biotechnology
VIR
$1.52B
| $19.7M | ﹤0.01% |
802,034
+415,089
| +107% | +$10.4M |
|
942
Leonardo DRS
DRS
$11.9B
| $19.6M | ﹤0.01% |
+1,132,713
| New | +$17.5M |
|
943
United Parks & Resorts
PRKS
$2.04B
| $19.6M | ﹤0.01% |
349,352
-54,301
| -13% | -$3.06M |
|
|
MRO
944
DELISTED
Marathon Oil Corporation
MRO
| $19.4M | ﹤0.01% |
843,693
-21,409
| -2% | -$504K |
|
945
Bio-Rad Laboratories Class A
BIO
$9.66B
| $19.4M | ﹤0.01% |
51,122
-350
| -0.7% | -$142K |
|
946
Array Technologies
ARRY
$796M
| $19M | ﹤0.01% |
841,943
+769,183
| +1,057% | +$16.5M |
|
|
EVRI
947
DELISTED
Everi Holdings
EVRI
| $19M | ﹤0.01% |
1,313,832
+2,203
| +0.2% | +$33.5K |
|
948
iShares Core S&P 500 ETF
IVV
$910B
| $19M | ﹤0.01% |
42,599
+10,148
| +31% | +$4.28M |
|
949
Evertec
EVTC
$1.91B
| $19M | ﹤0.01% |
515,006
+2,230
| +0.4% | +$77.3K |
|
950
Leidos
LDOS
$17.9B
| $19M | ﹤0.01% |
214,291
-55,576
| -21% | -$4.74M |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.